207 related articles for article (PubMed ID: 16818013)
1. Does prolonging the time to renal cancer surgery affect long-term cancer control: a systematic review of the literature.
Jewett M; Rendon R; Dranitsaris G; Drachenberg D; Tanguay S; Donnelly B; Fleshner N;
Can J Urol; 2006 Jun; 13 Suppl 3():54-61. PubMed ID: 16818013
[TBL] [Abstract][Full Text] [Related]
2. Does prolonging the time to bladder cancer surgery affect long-term cancer control: a systematic review of the literature.
Fradet Y; Aprikian A; Dranitsaris G; Siemens R; Tsihlias J; Fleshner N;
Can J Urol; 2006 Jun; 13 Suppl 3():37-47. PubMed ID: 16818011
[TBL] [Abstract][Full Text] [Related]
3. Does prolonging the time to prostate cancer surgery impact long-term cancer control: a systematic review of the literature.
Saad F; Finelli A; Dranitsaris G; Goldenberg L; Bagnell S; Gleave M; Fleshner N;
Can J Urol; 2006 Jun; 13 Suppl 3():16-24. PubMed ID: 16818008
[TBL] [Abstract][Full Text] [Related]
4. Does prolonging the time to testicular cancer surgery impact long-term cancer control: a systematic review of the literature.
Bell D; Morash C; Dranitsaris G; Izawa J; Short T; Klotz LH; Fleshner N;
Can J Urol; 2006 Jun; 13 Suppl 3():30-6. PubMed ID: 16818010
[TBL] [Abstract][Full Text] [Related]
5. Surgical wait times for patients with urological cancers: a survey of Canadian surgeons.
Fleshner N; Dranitsaris G; Finelli A; Tsihlias J; Bell D; Gleave M;
Can J Urol; 2006 Jun; 13 Suppl 3():3-13. PubMed ID: 16818006
[TBL] [Abstract][Full Text] [Related]
6. Impact of Time to Surgery and Surgical Delay on Oncologic Outcomes for Renal Cell Carcinoma.
Shiff B; Breau RH; Patel P; Mallick R; Tanguay S; So A; Lavallée L; Moore R; Rendon R; Kapoor A; Pouliot F; Finelli A; Bhindi B; Lattouf JB; Basappa N; Wood L; Heng D; Bjarnason G; Drachenberg D
J Urol; 2021 Jan; 205(1):78-85. PubMed ID: 32614274
[TBL] [Abstract][Full Text] [Related]
7. Consensus document: recommendations for optimal surgical wait times for patients with urological malignancies.
Canadian Surgical Wait Times (SWAT) Initiative
Can J Urol; 2006 Jun; 13 Suppl 3():62-4. PubMed ID: 16818014
[TBL] [Abstract][Full Text] [Related]
8. Waiting time from initial urological consultation to nephrectomy for renal cell carcinoma--does it affect survival?
Stec AA; Coons BJ; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE
J Urol; 2008 Jun; 179(6):2152-7. PubMed ID: 18423724
[TBL] [Abstract][Full Text] [Related]
9. Do Moderate Surgical Treatment Delays Influence Survival in Colon Cancer?
Wanis KN; Patel SVB; Brackstone M
Dis Colon Rectum; 2017 Dec; 60(12):1241-1249. PubMed ID: 29112559
[TBL] [Abstract][Full Text] [Related]
10. Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery.
Janssen MWW; Linxweiler J; Philipps I; Bütow Z; Siemer S; Stöckle M; Ohlmann CH
World J Surg Oncol; 2018 Feb; 16(1):35. PubMed ID: 29463251
[TBL] [Abstract][Full Text] [Related]
11. Guideline of guidelines: follow-up after nephrectomy for renal cell carcinoma.
Williamson TJ; Pearson JR; Ischia J; Bolton DM; Lawrentschuk N
BJU Int; 2016 Apr; 117(4):555-62. PubMed ID: 26617405
[TBL] [Abstract][Full Text] [Related]
12. Effect of Lean Processes on Surgical Wait Times and Efficiency in a Tertiary Care Veterans Affairs Medical Center.
Valsangkar NP; Eppstein AC; Lawson RA; Taylor AN
JAMA Surg; 2017 Jan; 152(1):42-47. PubMed ID: 27603225
[TBL] [Abstract][Full Text] [Related]
13. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
[TBL] [Abstract][Full Text] [Related]
14. Ipsilateral adrenalectomy at the time of radical nephrectomy impacts overall survival.
Yap SA; Alibhai SM; Abouassaly R; Timilshina N; Margel D; Finelli A
BJU Int; 2013 Mar; 111(3 Pt B):E54-8. PubMed ID: 23039377
[TBL] [Abstract][Full Text] [Related]
15. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival after radical surgery for renal cell carcinoma with tumour thrombus extension into the right atrium.
Dominik J; Moravek P; Zacek P; Vojacek J; Brtko M; Podhola M; Pacovsky J; Harrer J
BJU Int; 2013 Mar; 111(3 Pt B):E59-64. PubMed ID: 22984824
[TBL] [Abstract][Full Text] [Related]
17. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
18. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
